Angiotensin I, Plasma
Angiotensin I is a decapeptide formed as an intermediate during the synthesis of angiotensin II. Angiotensinogen, an α2-globulin synthesized in the liver is the precursor of angiotensin I. Renin, a proteolytic enzyme secreted from juxtaglomerular cells in the kidney, catalyzes the cleavage of the leucine-leucine peptide bond in angiotensinogen to produce angiotensin I. Angiotensin I comprises the first 10-amino-acid sequence and does not appear to have any biologic activity. Angiotensin I is then activated by angiotensin-converting enzyme (ACE) secreted by the lungs and is converted to angiotensin II, which is active form of the hormone.
Angiotensin II is a potent vasoconstrictor and stimulator of the zona glomerulosa to release aldosterone. Excessive production of angiotensin II is therefore associated with hypertension and secondary hyperaldosteronism. Angiotensin II has a very short half-life (1 to 2 minutes) and was traditionally difficult to measure. The measurement of renin activity (typically as ‘plasma renin activity’ PRA) was performed by allowing the patient’s plasma renin to act upon angiotensinogen to produce angiotensin I that is then measured. The results were expressed as angiotensin (ng) produced per mL of plasma per hour. Angiotensin I measurements were traditionally used as a surrogate for angiotensin II levels, however, recent methods to directly measure both renin and angiotensin II have been adopted by most laboratories. Therefore, the measurement of angiotensin I now has limited diagnostic utility.
- Concentration of angiotensin I is a reliable estimate of renin activity and angiotensin II concentration
- Aids in the differential diagnosis of primary and secondary aldosteronism
Increased in:
- Renal artery stenosis
- Secondary hyperaldosteronism
- Primary adrenal insufficiency
- 21-hydroxylase deficiency
- Steroid acute regulatory protein deficiency
- Reninoma
Decreased in:
- Primary hyperaldosteronism
- 11-β-hydroxylase deficiency
- 17- α-hydroxylase deficiency
- Primary glucocorticoid resistance
- Deoxycorticosterone (DOC) producing tumors
- Ectopic ACTH syndrome
<15 pmol/L
Plasma (EDTA)
Stability
- Ambient: unacceptable
- Refrigerated: unacceptable
- Frozen: 1 month
- Methods Mol Med. 2001;51:267–73. [PMID: 21331723]
- Anal Biochem. 2009;388:134–9. [PMID: 19258005]
- Methods Mol Biol. 2006;324:187–96. [PMID: 16761379]
- Clin Chem. 2009;55:867–77. [PMID: 19264850]
- Methods Mol Biol. 2017;1527:81–99. [PMID: 28116709]